Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-04-05 @ 10:16 PM
Study NCT ID:
NCT07449234
Status:
RECRUITING
Last Update Posted:
2026-03-13
First Post:
2026-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis
Sponsor:
Janssen-Cilag Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CNTO1959PSO4032
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None